|
| 益方生物-U(688382)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-07-25 | 1276.57 | 2.21% | 41245.35 | 16426.41 | 39968.78 | 69.30% | 首发原股东限售股份 | | 2024-07-25 | 345.00 | 0.60% | 39797.01 | 17702.99 | 10569.28 | 18.38% | 首发战略配售股份 | | 2023-09-18 | 10380.82 | 18.05% | 39452.01 | 18047.99 | 11155.00 | 19.40% | 首发原股东限售股份 | | 2023-09-08 | 17916.19 | 31.16% | 29071.19 | 28428.81 | 11155.00 | 19.40% | 首发原股东限售股份 | | 2023-07-25 | 650.17 | 1.13% | 11155.00 | 46345.00 | 10569.28 | 18.38% | 首发战略配售股份 | | 2023-01-30 | 555.53 | 0.97% | 10569.28 | 46930.72 | 10569.28 | 18.38% | 首发机构配售股份 | | 2022-07-25 | 9949.30 | 17.30% | 9949.30 | 47550.70 | 9949.30 | 17.30% | 首发一般股份 |
|